OTC HIV tests: 42% of at-risk survey respondents said they "likely" would use test-- NEJM.
This article was originally published in The Gray Sheet
HOME HIV TESTS: 42% OF AT-RISK INDIVIDUALS SURVEYED WOULD "LIKELY" USE the test if it were approved by FDA for over-the-counter use, Kathryn Phillips, PhD, University of California-San Francisco, et al. note in a study published in the May 11 New England Journal of Medicine. The study found that 42% of 2,523 respondents to a national health survey who were deemed to be at risk for HIV said they would be "very or somewhat likely to use home tests" for the virus. Sixty-three percent of this group noted that they had never been tested for HIV, excluding testing for blood donations.
You may also be interested in...
As the first emergency use authorization is granted, Pfizer and Moderna stand accused of neglecting poorer nations as wealthy countries snap up early access to COVID-19 vaccines.
The FDA has released final guidance on “Formal Meetings Between FDA and ANDA Applicants of Complex Products Under GDUFA” for the industry. The guidance brings clarity and aims at facilitating product development meetings between the FDA and the ANDA applicants for complex products.
By handing out free supplements to the clinically vulnerable, the UK government is effectively endorsing the use of vitamin D to reduce the risk and/or severity of COVID-19, although it says more research is needed.